Genincode PLC
LSE:GENI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genincode PLC
LSE:GENI
|
UK |
|
I
|
InfoBankCorp
KOSDAQ:039290
|
KR |
|
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
IN |
|
Y
|
Yongmao Holdings Ltd
SGX:BKX
|
SG |
|
BICO Group AB
STO:BICO
|
SE |
|
Lenta Plc
LSE:LNTA
|
RU |
|
Bharatiya Global Infomedia Ltd
NSE:BGLOBAL
|
IN |
|
Cosmo Advanced Materials & Technology Co Ltd
KRX:005070
|
KR |
|
Phibro Animal Health Corp
NASDAQ:PAHC
|
US |
|
B
|
Biolog Device Co Ltd
KOSDAQ:208710
|
KR |
|
B
|
Bifido Co Ltd
KOSDAQ:238200
|
KR |
|
C
|
Celestica Inc
NYSE:CLS
|
CA |
|
P
|
Pebble Beach Systems Group PLC
LSE:PEB
|
UK |
|
B
|
Bengal Tea & Fabrics Ltd
BSE:532230
|
IN |
Genincode PLC
GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.
GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
